Drug intelligence / Profile preview

Estromineral

Development stage: Preclinical
Lead developer: Rotta Research
Administration: Oral

Overview

Estromineral is a food supplement developed by Rottapharm, formulated to address menopausal symptoms and support bone health. It comprises a combination of natural ingredients including isoflavones, Lactobacillus sporogenes, Vitamin D3, and calcium. The isoflavones are primarily responsible for reducing vasomotor symptoms such as hot flushes and night sweats, with their absorption enhanced by the presence of Lactobacillus sporogenes. Additionally, Vitamin D3 and calcium work synergistically to strengthen bone mineralization, which is crucial during menopause.

Brand names: Estromineral

Targets

ER (Estrogen receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Estromineral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estromineral.

Explore the full profile